We are live on ! Find out more
PAI

ProQuest Associates IV Portfolio holdings

AUM $53M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
+39.14%
1 Year Est. Return
+3.35%
3 Year Est. Return
+113.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
–
Cap. Flow
+$177M
Cap. Flow %
89.82%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMDZ
Immune Design Corp.
IMDZ
+$74.9M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$60.5M
3
AGRX
Agile Therapeutics
AGRX
+$24.5M
4
ACHN
Achillion Pharmaceuticals
ACHN
+$13.7M
5
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
+$2.27M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMDZ
1
DELISTED
Immune Design Corp.
IMDZ
$83M 42.05%
+2,695,757
New +$74.9M
EGRX
2
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$73.5M 37.25%
+4,741,187
New +$60.5M
AGRX
3
DELISTED
Agile Therapeutics
AGRX
$23.7M 12%
+1,928
New +$24.5M
ACHN
4
DELISTED
Achillion Pharmaceuticals
ACHN
$13.8M 6.97%
+1,122,957
New +$13.7M
ANTH
5
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.98M 1%
+156,250
New +$2.27M
SVRA icon
6
Savara
SVRA
$1.08B
$1.43M 0.72%
+36,455
New +$1.27M

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
HC
Hampstead Capital London, United Kingdom $55.8M AUM 2.76% 1-Year Est. Return
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return

ProQuest Associates IV's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for ProQuest Associates IV, which disclosed 6 positions worth $197M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Immune Design Corp.: 2,695,757 shares worth $83M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • ProQuest Associates IV's largest Q4 2014 buy was Immune Design Corp.: 2,695,757 shares worth $83M.
  • ProQuest Associates IV's ten largest holdings make up 100% of its $197M portfolio in Q4 2014.
  • ProQuest Associates IV disclosed 6 positions in Q4 2014, its first 13F filing on record.

Based on ProQuest Associates IV's 13F filing for Q4 2014, filed 13 Feb 2015.